Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Companies / Mapp Biopharmaceutical
Entity

Mapp Biopharmaceutical

Tracked across 3 events · 517 articles · First seen May 18, 2026 · Last active Jun 02, 2026

Sentiment
23
Attention
8
Events
3
Relationships
16
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (3)
6 60
Tech
WHO Prioritizes Ebola Bundibugyo Treatments
The World Health Organization has recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola: Mapp Biopharmaceutical's MBP134, Regeneron Pharmaceuticals' maftivimab, and Gilead Sciences' remdesivir. These, along with other vaccine candidates, are to be…
Impact: Mapp Biopharmaceutical developed MBP134, one of the experimental treatments prioritized by the World Health Organization for the Bundibugyo strain of Ebola.
May 28, 2026 · 6 articles
8 10
Accidents
Unknown Event
Impact: Mapp Biopharmaceutical>>>'s pan-ebolavirus antibody drug, MBP134, is a potential candidate for clinical trials against the Uganda — Bundibugyo strain, with development backed by BARDA.
May 18, 2026 · 505 articles
4 0
Regulatory
Beyond_Air Nasdaq Listing Extension Granted
q.beyond, a medical device and biopharmaceutical company, has received an extension from the Nasdaq-100 Hearings Panel to regain compliance with Nasdaq-100's bid price rule by July 31, 2026. The company's stock has been trading below…
Impact: q.beyond terminated its proposed transaction with Mapp Biopharmaceutical for the sale of its NeuroNOS subsidiary, indicating a change in strategic plans for q.beyond's assets.
Jun 01, 2026 · 6 articles
Key Actions (2)
40 Mapp Biopharmaceutical developed MBP 134
20 q.beyond terminated transaction Mapp BiopharmaceuticalBeyond_Air Nasdaq Listing...
Relationships (16)
International AIDS Vaccine Initiative ↔ Mapp Biopharmaceutical
International AIDS Vaccine Initiative ↔ Mapp Biopharmaceutical
Serum Institute of India ↔ Mapp Biopharmaceutical
Serum Institute of India ↔ Mapp Biopharmaceutical
Merck & Co. ↔ Mapp Biopharmaceutical
Merck & Co. ↔ Mapp Biopharmaceutical
Regeneron Pharmaceuticals ↔ Mapp Biopharmaceutical
Regeneron Pharmaceuticals ↔ Mapp Biopharmaceutical
Gilead Sciences ↔ Mapp Biopharmaceutical
Gilead Sciences ↔ Mapp Biopharmaceutical
Democratic Republic of the Congo ↔ Mapp Biopharmaceutical
Democratic Republic of the Congo ↔ Mapp Biopharmaceutical
United States — Centers for Disease Control and Prevention ↔ Mapp Biopharmaceutical
United States — Centers for Disease Control and Prevention ↔ Mapp Biopharmaceutical
World Health Organization ↔ Mapp Biopharmaceutical
World Health Organization ↔ Mapp Biopharmaceutical
NEWSDESK
Track Mapp Biopharmaceutical live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.